Company Filing History:
Years Active: 2019-2025
Title: Maurice Abiad: Innovator in Pharmaceutical Compositions
Introduction
Maurice Abiad is a notable inventor based in Anaheim, CA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the stabilization of Clostridial toxins. With a total of 5 patents to his name, Abiad's work has the potential to impact medical treatments significantly.
Latest Patents
Abiad's latest patents focus on non-protein Clostridial toxin compositions. These pharmaceutical compositions are designed to stabilize a Clostridial toxin active ingredient. The compositions can be either liquid or solid and include a surfactant and an antioxidant. In some embodiments, the compositions feature a surfactant selected from poloxamer and polysorbate, along with an antioxidant chosen from methionine, N-acetyl cysteine, ethylenediaminetetraacetic acid, and combinations thereof. Additionally, the compositions may optionally contain a tonicity agent and/or a lyoprotector, such as trehalose or sucrose.
Career Highlights
Abiad is currently associated with Allergan, Inc., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential applications in medical treatments, particularly in the area of toxin stabilization.
Collaborations
Abiad has collaborated with notable colleagues, including Bhas Dani and Evgenyi Shalaev. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Maurice Abiad's contributions to pharmaceutical compositions, particularly in stabilizing Clostridial toxins, highlight his innovative spirit and dedication to advancing medical science. His work at Allergan, Inc. and his collaborations with esteemed colleagues further underscore his impact in the field.